Richard O'Reilly MB, MRCP(I), MRCPsych, FRCPC.

Professor Emeritus

Therapeutic Brian Stimulation Clinic

Med School: Trinity college Dublin, Ireland
Residency: Western University, Canada
E-mail: roreilly@uwo.ca
Phone: 519.455.5110 x48723

Profile

Dr. Richard O’Reilly is a professor of psychiatry at Western University and at the Northern Ontario School of Medicine. He obtained his medical degree in Trinity College Dublin. Dr. O’Reilly has a specialist qualification in psychiatry from the Royal College of Psychiatrists in the United Kingdom and also from the Royal College of Physicians and Surgeons in Canada. Prior to obtaining his psychiatric qualifications Dr. O’Reilly trained in internal medicine and obtained his specialist qualification as Member of the College of Physicians of Ireland. Dr. O’Reilly works in the Therapeutic Brain Stimulation Clinic at the Parkwood Institute. His research interests are the genetics of schizophrenia and mental health law.

Publications

  1. Dufour M, Hastings T, O’Reilly R. Canada should retain its reservation on the United Nation’s Convention on the Rights of Persons with Disabilities. Can J Psychiatry [Perspectives]). Published online: June 20, 2018. 2018 Jun 20, Coauthor

  2. Guaiana G, O’Reilly R, Grassi L. A comparison of inpatient adult psychiatric services in Italy and Canada. Community Ment Health J. Community Ment Health J. Published online May 3, 2018. https://doi.org/10.1007/s10597-018-0283-3, 2018 May 3, Coauthor

  3. Corring D, O’Reilly R, Sommerdyk C. Russell E. What clinicians say about the experience of working with individuals on Community Treatment Orders (CTOs). Psychiatr Serv. Published online: April 26, 2018; https://doi.org/10.1176/appi.ps.201700492, 2018 Apr 26, Coauthor

  4. O’Reilly R, Vingilis E. Are randomized controlled trials the best method to assess the effectiveness of community treatment orders? Adm Policy Ment Health, 2017; https://doi.org/10.1007/s10488-017-0845-7, 2017 Nov 29, Principal Author

  5. Castellani CA, Melka MG, Gui JL, Gallo AJ, O’Reilly RL, Singh SM. Post-zygotic genomic changes in glutamate and dopamine pathway genes may explain discordance of monozygotic twins for schizophrenia. Clin Trans Med 2017, 6:43.DOI 10.1186/s40169-017-0174-1, 2017 Nov 28, Coauthor

  6. McDonald C, O’Reilly R, Kelly B, Burns T. Community treatment orders should be introduced in the Republic of Ireland. Ir J Psychol Med, 2017; 34(4), 295-303. doi:10.1017/ipm.2017.42, 2017 Nov 23, Coauthor

  7. O’Reilly R, Shum JY-H, Grassi L. The pitfalls of comparing psychiatric bed numbers across jurisdictions: Lessons from Canada and Italy. Research Insights, St. Joseph’s Health Care London 2017; 14(2); 2-8. Research Insights, St. Joseph’s Health Care London 2017; 14(2); 2-8. 2017 Nov 1, Principal Author

  8. Karagianis J, Muslant B, Dawe I, Bhatla R, Bergstrome B, O’Reilly R. Too sick for freedom, too healthy for treatment. Untreatable patients in forensic psychiatry: A literature review. published on line September 2, 2017, DOI 10.7590/221354017X14994239140324 2213-5405, Coauthor

  9. Corring D, O’Reilly R, Sommerdyk C. A systematic review of the views and experiences of subjects of community treatment orders. International Journal of Law and Psychiatry, 2017 May; 52: 74-80, Co-Principal Author

  10. Kisely SR, Campbell LA, O’Reilly R. Compulsory community and involuntary outpatient treatment for people with severe mental disorders. 2017 Mar 17;3:CD004408. doi: 10.1002/14651858.CD004408.pub5. [Epub ahead of print], Coauthor

  11. Hurley D, O’Reilly RL. Resilience mental health and assertive community treatment. published online March 8, 2017, Coauthor, DOI: 10.1080/15332985.2017.1302038.

  12. Reble E, Castellani CA, Melka MG, O’Reilly R, Singh SM. VarScan2 analysis of de novo variants in monozygotic twins discordant for schizophrenia. Psychiatr Genet, 2017 Jan 5 (2): 62-70, Collaborator

  13. Bastiampillai T, Sharfstein S, Allison S. Contributors: O’Reilly R, Tyrer P. Increase in US suicide rates and the critical decline in psychiatric beds. JAMA. Published online November 3, 2016. doi:10.1001/jama.2016.16989. JAMA, 2016 Nov 3, Collaborator, DOI: 10.1001/jama.2016.16989.

  14. O’Reilly R, Corring D, Richard J, Plyley C, Pallaveshi L. Do intensive services obviate the need for CTOs? Int J Law Psychiatry, 2016 Jul 1; 47: 74-8, Principal Author, DOI: 10.1016/j.ijlp.2016.02.038.

  15. Gray JE, Hastings TJ, Love S, O’Reilly RL. Clinically Significant Differences among Canadian Mental Health Acts: 2016. Can J Psychiatry, 2016 Apr 1; 61 (4): 222-6, Coauthor, DOI: 10.1177/0706743716632524.

  16. Castellani CA, Melka MG, Gui JL, O’Reilly RL, Singh SM. Integration of DNA sequence and DNA methylation changes in monozygotic twin pairs discordant for schizophrenia. Schizophr Res, 2015 Dec 1; 169 (1-3): 433-40, Collaborator, DOI: 10.1016/j.schres.2015.09.021.

  17. Dawson J, O’Reilly R. Residence conditions on community treatment orders. Can J Psychiatry, 2015 Nov 1; 60 (11): 523-7, Co-Principal Author

  18. O’Reilly RL, Gray JE, Jung J. Sharing information with families that carry burden of care for relatives with severe mental illness. Journal of Ethics in Mental Health, 2015 Nov; Open volume: 1-5, Principal Author

  19. Melka MG, Castellani CA, O’Reilly R, Singh SM. Insights into the origin of DNA methylation differences between monozygotic twins discordant for schizophrenia. 3:7, doi:10.1186/s40303-015-0013-5, Collaborator, DOI: doi:10.1186/s40303-015-0013-5.

  20. Kisely SR, O’Reilly RL. Reappraising community treatment orders: Can there be a consensus? Med J Aust 2015; 202 (8): 415-416, Co-Principal Author

  21. Castellani CA, Laufer BI, Melka MG, Diehl EJ, O’Reilly RL, Singh S. DNA methylation differences in monozygotic twin pairs discordant for schizophrenia identifies psychosis related genes and networks. 3:7 doi:10.1186/s40303-015-0013-5, Collaborator, DOI: doi:10.1186/s40303-015-0013-5.

  22. Melka MG, Rajakumar N, O’Reilly R, Singh SM. Olanzapine-induced DNA methylation in the hippocampus and cerebellum in genes mapped to human 22q11 and implicated in schizophrenia. Psychiatr Genet. 2015 Apr;25(2):88-94. Collaborator

  23. Castellani C, Melka M, Diehl E, Laufer B, O’Reilly RL, Singh SM. DNA methylation in psychosis: Insights into aetiology and treatment. Epigenomics 2015; 7(1):67-74, Collaborator

  24. Melka MG, Castellani CA, Rajakumar N, O’Reilly R, Singh SM. Olanzapine-induced methylation alters cadherin gene families and associated pathways implicated in psychosis. BMC Neuroscience, 2014; 15:112. BMC Neuroscience, 2014; 15:112. Collaborator

  25. O’Reilly RL, Gray JE. Canada’s Mental Health Legislation. 2014, 11(3):65-67, Principal Author

  26. Castellani CA, Melka MG, Wishart AE, Locke MEO, Awamleh Z, O’Reilly R, Singh SM. Biological relevance of CNV calling methods using familial relatedness including monozygotic twins. BMC Bioinformatics. 2014 Apr 21;15:114. doi: 10.1186/1471-2105-15-114. Collaborator, DOI: 10.1186/1471-2105-15.

  27. Castellani CA, Awamleh Z, Melka M, O’Reilly RL, Singh SM. Copy number variation distribution in six monozygotic twin pairs discordant for schizophrenia. Twin Res Hum Genet, 2014 Apr;17(2):108-20. doi: 10.1017/thg.2014.6. Epub 2014 Feb 20, Coauthor

  28. Melka MG, Laufer BL, McDonald P, Castellani C, Rajakuma RN, O’Reilly R, Singh SM. The effects of olanzapine on genome-wide DNA methylation in hippocampus and cerebellum. Clin Epigenetics 2014; 6(1):1, Collaborator

  29. Melka MG, Castellani CA, Laufer BI, Rajakumar RN, O’Reilly R, Singh SM. Olanzapine induced DNA methylation changes support the dopamine hypothesis of psychosis. J Mol Psychiatry 2013, 1:19, Coauthor

  30. Kumar K, Castellani C, Maiti S, O’Reilly R, Singh S. Search for missing schizophrenia genes require a new developmental neurogenomic perspective. J Genet 2013 Aug; 92(2), Collaborator

  31. Kumar K, Maiti S, Castellani CA, O’Reilly R, Singh SM. A novel deletion cluster at 13q14.2-q21.33 in an 80-year old man with onset leukemia: clinical and molecular findings. Indian J Hum Genet [serial online] 2013 [cited 2013 Jun 11];19:96-100. Available from: http://www.ijhg.com/text.asp?2013/19/1/96/112916, Coauthor

  32. O’Reilly R, Torrey EF, Rao J, Singh S. Monozygotic twins with early onset schizophrenia and late onset bipolar disorder: A case report. J Med Case Reports 2013, 7:134. doi:10.1186/1752-1947-7-134. http://www.jmedicalcasereports.com/content/7/1/134, Principal Author

  33. Gowda K, Rao J, O’Reilly R, Singh S. Molecular analysis of candidate genes at the 22q region in schizophrenia subjects. . Research in Biotechnology 2012; 3(6):24-32. http://www.researchinbiotechnology.com/view/article/3/6/3. Research in Biotechnology, 2012 Dec; 3 (6): 24-32, Coauthor

  34. O’Reilly R, Solomon R, Gray J. Reforms to Ontario’s Mental Health Act: Lessons from the story of the man who killed Brian Smith. Research Insights of RMHC London and St. Thomas 2012; (9)3. Principal Author

  35. O’Reilly R, Dawson J, Burns T. Best practices in the use of involuntary outpatient treatment. Psychiatr Serv, 2012 May; 63 (5): 421-423, Principal Author

  36. Maiti S, O’Reilly R, Kumar K, Castellani CA, Singh SM. Ontogenetic de novo copy number variations (CNVs) as a source of genetic individuality: Studies on two families with MZD twins for schizophrenia. PLoS ONE Mar, 2011 Mar; 6 (3): e17125, Coauthor

  37. McDonald P, O’Reilly R, Singh SM. Methylation analysis of the NOTCH4 -25 C/T polymorphism in schizophrenia. Psychiatr Genet Feb, 2011 Feb; 21 (1): 5-13, Coauthor

  38. Gray JE, McSherry BM, O’Reilly RL, Weller PJ. Australian and Canadian mental health laws compared. Aust N Z J Psychiatry. 2010 Dec; 44 (12): 1126-31, Coauthor

  39. O’Reilly RL, Chaimowitz G, Brunet A, Looper K, Beck P. Principles Underlying Mental Health Legislation. [CPA position paper]. Can J Psychiatry 2010; 55(10); Insert 1-6, Principal Author

  40. Carr PE, Brooks S, Chaimowitz G, Looper K, Milev R, O’Reilly R, Pankratz W, White PJ. Prescription of psychotropic medication. [CPA position statement]. Can J Psychiatry, 2010 May; 55 (5): Insert 1-2, Coauthor

  41. Brooks SA, O’Reilly RL. Mental health legislation: Committal. [CPA discussion paper]. Can J Psychiatry, 2010 Apr; 55 (4): Insert 1-6, Coauthor

  42. O’Reilly RL, Solomon R, Gray JE. An Exchange of Views: What constitutes reasonable review of treatment capacity. Research Insights of RMHC London and St. Thomas 2009; 6(2), Principal Author

  43. Singh SM, Castellani C, O’Reilly R. Autism meets schizophrenia via cadherin pathway. Schizophr Res Feb, 2009 Oct; 116 (2-3): 293-294, Coauthor

  44. Gray JE, O’Reilly RL. Supreme Court of Canada’s “Beautiful Mind” case. Int J Law Psychiatry 2009; 32:315-322, Coauthor

  45. Carr PE, Brooks S, Chaimowitz G, Looper K, Milev R, O’Reilly R, Pankratz W, Warneke LB, White PJ. Psychosurgery. [CPA position statement]. Can J Psychiatry 2009; 54(7). Coauthor

  46. Solomon R, O’Reilly R, Nikolic M, Gray JE. Treatment delayed – liberty denied. Can Bar Rev Jun, 2009 Jun; 87 (3): 679-719, Coauthor

  47. Singh SM, Castellani C, O’Reilly RL. Copy number variation showers in schizophrenia: An emerging hypothesis. Mol Psychiatry 2009; 14:356-358. Coauthor

  48. Singh SM, O’Reilly R. (Epi)genomics and neurodevelopment in schizophrenia: Monozygotic twins discordant for schizophrenia augment the search for disease-related (epi)genomic alterations. Genome 2009; 52:8-19, Coauthor

  49. Murphy BC, O’Reilly R, Singh SM. DNA methylation and mRNA expression of SYN III, a candidate gene for schizophrenia. BMC Med Genet 2008; 9:115, Coauthor

  50. O’Reilly RL. The capacity to execute an advance directive for psychiatric treatment. Int J Law Psychiatry, 2008 Jan; 31 (1): 66-71, Principal Author

  51. O’Reilly RL. Reply: Community treatment orders: An essential therapeutic tool in the face of continuing deinstitutionalization (Letter). Can J Psychiatry, 2007 Aug; 52 (8): 542, Principal Author

  52. O’Reilly RL, Bishop J, Maddox K, Hutchinson L, Fisman M, Takhar J. Is telepsychiatry equivalent to face-to-face psychiatry? Results from a randomized controlled equivalence trial. Psychiatr Serv Jun, 2007 Jun; 58 (6): 836-43, Principal Author

  53. Vandevooren J, Miller L, O’Reilly R. Outcomes in community-based residential treatment and rehabilitation for individuals with severe psychiatric disabilities: A retrospective study. Psychiatr Rehabil J Winter, 2007 Jan; 30 (3): 215-217, Coauthor

  54. Gray JE, O’Reilly RL. Canadian approaches to mandatory community treatment: Least restrictive alternatives? Research Insights of RMHC London/St. Thomas 2007;4(1), Coauthor

  55. O’Reilly RL, Keegan DL, Corring D, Shrikhande S, Natarajan D. A qualitative analysis of the use of community treatment orders in Saskatchewan. Int J Law Psychiatry, 2006 Nov; 29 (6): 516-524, Principal Author

  56. O’Reilly, RL. Community treatment orders: An essential therapeutic tool in the face of continuing deinstitutionalization. Can J Psychiatry, 2006 Oct; 51 (11): 686-688, Principal Author

  57. O’Reilly RL. Community treatment orders: This emperor is fully dressed! Can J Psychiatry, 2006 Oct; 51 (11): 691, Principal Author

  58. Uddin RK, Zhang Y, Siu VM, Fan YS, O’Reilly RL, Rao J, Singh SM. Breakpoint associated with a novel 2.3Mb deletion in the VCFS region of 22q11 and the role of Alu (SINE) in recurring microdeletions. BMC Med Genet 2006 Mar 2;7:18, Collaborator

  59. Hoch J, O’Reilly RL, Carscadden J. Relationship management therapy for patients with borderline personality disorder. Psychiatr Serv Feb, 2006 Feb; 57 (2): 179-81, Coauthor

  60. Murphy BC, O’Reilly RL, Singh SM. Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia. Am J Med Genet B Neuropsychiatr Genet, 2005; 133B (1): 37-42, Coauthor

  61. Gray JE, O’Reilly RL. Canadian compulsory community treatment laws: Recent reforms. Int J Law Psychiatry, 2005; 28 (1): 13-22, Coauthor

  62. O’Reilly RL. Does exposure to analgesics in utero cause schizophrenia? Pain Res Manag, 2005; 10 (3): 129-130, Principal Author

  63. O’Reilly RL, Gray JE. Is mandatory outpatient treatment effective? Can J Commun Ment Health, 2005; 24 (2): 77-83, Principal Author

  64. Singh SM, McDonald P, Murphy BC, O’Reilly RL. Incidental neurodevelopmental episodes in the etiology of schizophrenia: An expanded model involving epigenetics and development. Clin Genet, 2004; 65 (6): 435-440, Collaborator

  65. O’Reilly RL. Why are community treatment orders controversial? Can J Psychiatry, 2004; 49 (9): 579-584, Principal Author

  66. Brooks SA, O’Reilly RL, Gray JE. Implications for psychiatrists of the Supreme Court of Canada Starson v. Swayze Decision. Canadian Psychiatric Assn Bulletin, 2003 Aug; 35 (4): 28, Coauthor

  67. O’Reilly RL, Gray JE. Rapid Response to: The psychiatric protection order for the “battered mental patient”. [Letter]. BMJ 2003; 327:1449-1451, Principal Author

  68. O’Reilly RL, Karlinsky H, Tempier R, Gray JE. A survey of Canadian psychiatrists’ experience and opinions on using videoconferencing for assessments required by mental health legislation. Canadian Psychiatric Assn Bulletin, 2003; 35 (5): 18-20, Principal Author

  69. Singh SM, Murphy BC, O’Reilly RL. Involvement of gene-diet/drug interaction in DNA methylation and its contribution to complex diseases: From cancer to schizophrenia. Clin Genet, 2003; 64 (6): 451-460, Collaborator

  70. McDonald P, Lewis MJ, Murphy BC, O’Reilly RL, Singh SM. Appraisal of genetic and epigenetic congruity of a monozygotic twin pair discordant for schizophrenia. J Med Genet, 2003; 40 (2): e16, Collaborator

  71. O’Reilly RL, Gray JE. Can we justify delays in initiating treatment for involuntary patients? Research Insights of RMHC London/St. Thomas 2003;2(3), Principal Author

  72. O’Reilly RL, Brooks SA, Chaimowitz GA, Neilson GE, Carr PE, Zikos E, Leichner P, Beck P. Mandatory outpatient treatment [CPA position paper]. Can J Psychiatry, 2003; 48 (7): Insert:, Principal Author

  73. Kelly M, Dunbar S, Gray JE, O’Reilly RL. Treatment delays for involuntary psychiatric patients associated with reviews of treatment capacity. Can J Psychiatry, 2002; 47 (2): 181-185, Collaborator

  74. Deb-Rinker P, O’Reilly RL, Torrey EF, Singh SM. Molecular characterization of a 2.7-kb, 12q13-specific, retroviral-related sequence isolated by RDA from monozygotic twin pairs discordant for schizophrenia. Genome, 2002; 45 (2): 381-390, Coauthor

  75. O’Reilly RL. Rebuttal to Letter by Dr. E. M. Goldner to article, Seven deadly sins of mental health reform. Canadian Psychiatric Assn Bulletin, 2002; 34 (2): 9, Principal Author

  76. Bishop JE, O’Reilly RL, Maddox K, Hutchinson LJ. Client satisfaction in a feasibility study comparing face-to-face interviews with telepsychiatry. J Telemed Telecare, 2002; 8 (4): 217-221, Coauthor

  77. Singh SM, Murphy BC, O’Reilly RL. Monozygotic twins with chromosome 22q11 deletion and discordant phenotypes: Update with an epigenetic hypothesis. J Med Genet; 2002;39:e71, Collaborator

  78. Singh SM, Murphy BC, O’Reilly RL. Epigenetic contributors to the discordance of monozygotic twins. Clin Genet 2002; 62:97-103, Collaborator

  79. Cernovsky ZZ, Landmark JA, O’Reilly RL. Age of onset and symptoms patterns in schizophrenia. Eur J Psychiat, 2002; 16 (3): 168-173, Collaborator

  80. O’Reilly RL, Lane A, Cernovsky ZZ, O’Callaghan E. Neurological soft signs, minor physical anomalies and handedness in schizophrenia. Eur J Psychiat, 2001; 15 (3): 189-192, Principal Author

  81. Gray JE, O’Reilly RL. Clinically significant differences among Canadian mental health law. Can J Psychiatry 2001;46:315-321, Coauthor

  82. O’Reilly RL. Does involuntary out-patient treatment work? Psychiatr Bull 2001; 25:371-374, Principal Author

  83. O’Reilly RL, Bishop JE. Assessing the New York City involuntary outpatient treatment program. [Letter]. Psychiatr Serv 2001; 52:1533, Principal Author

  84. O’Reilly RL. Seven deadly sins of mental health reform. Canadian Psychiatric Assn Bulletin, 2001; 33 (3): 17-20, Principal Author

  85. O’Reilly RL, Keegan DL, Elias J. A survey of the use of community treatment orders by psychiatrists in Saskatchewan. Can J Psychiatry, 2000; 45 (1): 79-81, Principal Author

  86. O’Reilly RL. Intervening early in psychosis. [Letter]. Ann R Coll Physicians Surg Can, 2000; 33 (2): 115, Principal Author

  87. O’Reilly RL, Chamberlaine CH. Criteria for admission to psychiatric units: Have we raised the bar too high? [Letter]. Can J Psychiatry, 2000; 45 (4): 392, Principal Author

  88. Haggarty J, O’Reilly RL. Native mental health: More questions than answers. Canadian Psychiatric Assn Bulletin, 2000; 32 (3): 88-89, Coauthor

  89. O’Reilly RL, Komer W, Dunbar S. Why are patients discharged by review boards? Can J Psychiatry, 1999; 44 (3): 259-263, Principal Author

  90. Deb P, Klempan TA, O’Reilly RL, Singh SM. Search for retroviral related DNA polymorphisms using RAPD PCR in schizophrenia. Biochim Biophys Acta, 1999; 1453 (2): 216-220, Collaborator

  91. Cernovsky ZZ, O’Reilly RL, Litman LC. Psychopathology and consumer satisfaction with substance abuse treatment program. Canadian Psychiatric Assn Bulletin, 1999; 31 (1): 21-24, Coauthor

  92. Komer W, O’Reilly R, Cernovsky Z, Dunbar S. Review board outcome for involuntary patients in psychiatric hospitals. Can J Psychiatry, 1999; 44 (5): 495-498, Coauthor

  93. Deb-Rinker P, Klempan TA, O’Reilly RL, Torrey EF, Singh SM. Molecular characterization of a MSRV-like sequence identified by RDA from monozygotic twin pairs discordant for schizophrenia. Genomics, 1999; 61 (2): 133-144, Collaborator

  94. O’Reilly RL. Is hospitalization bad for psychiatric patients? [Letter]. Can J Psychiatry. 1999; 44 (7): 709, Principal Author

  95. O’Reilly, RL. Mental health legislation and the right to appropriate treatment. Can J Psychiatry, 1998; 43 (8): 811-815, Principal Author

  96. Deb P, Klempan TA, O’Reilly RL, Singh SM. A single-primer PCR-based retroviral-related DNA polymorphism shared by two distinct human populations. Genome 1998; 41:662-668, Collaborator

  97. Cernovsky ZZ, Landmark JA, Merskey H, O’Reilly RL. The relationship of catatonia symptoms to symptoms of schizophrenia. Can J Psychiatry, 1998; 43 (10): 1031-1035, Collaborator

  98. Cernovsky ZZ, O’Reilly RL, Pennington M. Antisocial personality traits and patients’ satisfaction with treatment for addiction. Psychol Rep 1997; 80:275-282, Coauthor

  99. O’Reilly RL. A time to bury the tricyclic antidepressants or to praise them? Can J Psychiatry, 1997; 42 (4): 427-428, Principal Author

  100. Cernovsky ZZ, Landmark JA, O’Reilly RL. Symptom patterns in schizophrenia for men and women. Psychol Rep 1997; 80:1267-1271, Collaborator

  101. Cernovsky ZZ, O’Reilly RL, Pennington M. Sensation seeking scales and consumer satisfaction with a substance abuse treatment program. J Clin Psychol, 1997; 53 (8): 779-784, Coauthor

  102. O’Reilly RL, Singh SM. Retroviruses and schizophrenia revisited. Am J Med Genet 1996; 67:19-24, Principal Author

  103. O’Reilly RL, Chamberlaine C. Charles Bonnet syndrome: Incidence and demographic and clinical features. [Letter]. Can J Psychiatry, 1996; 41 (4): 259-260, Principal Author

  104. Shrikande S, O’Reilly R, Davis B, Durden D, Malcolm D. Plasma phenylethylamine levels of schizophrenic patients. [Letter]. Can J Psychiatry, 1995; 40 (4): 221, Coauthor

  105. Ravindran AV, Teehan MD, Bakish D, Yatham L, O’Reilly R, Fernando ML, Manchanda R, Charbonneau Y, Buttars J. The impact of sertraline, desipramine, and placebo on psychomotor functioning in depression. Hum Psychopharmacol 1995; 10:273-281, Collaborator

  106. O’Reilly RL, Davis BA. Phenylethylamine and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18:63-75, Principal Author

  107. O’Reilly RL. Viruses and schizophrenia. Aust N Z J Psychiatry 1994; 28:222-228, Principal Author

  108. O’Reilly RL, Bogue L, Singh SM. Pharmacogenetic response to antidepressants in a multicase family with affective disorder. Biol Psychiatry 1994; 36:467-471, Principal Author

  109. Cernovsky ZZ, O’Reilly RL, Landmark J. Birth order, family size, and schizophrenic symptoms. Soc Behav Pers, 1994; 22 (3): 291-296, Coauthor

  110. Remillard AJ, O’Reilly R, Gorecki DK, Blackshaw SL, Quinn D, Keegan DL. The noncompliance factor in the dexamethasone suppression test. Biol Psychiatry 1993; 33:755-756, Coauthor

  111. O’Reilly RL, Smith DW, Freeland A, Cernovsky ZZ. Antisocial attitude and consumer satisfaction with a substance abuse treatment program. Soc Behav Pers 1993; 21:159-162, Principal Author

  112. Freeland A, O’Reilly RL. Musical hallucinations: Another case report [Letter]. Can J Psychiatry, 1992; 37 (10): 731, Coauthor

  113. O’Reilly RL. Are the monoamine oxidase inhibitors facing extinction? Can J Psychiatry, 1991; 36 (3): 186-189, Principal Author

  114. Truant G, O’Reilly R, Donaldson L. How psychiatrists weigh risk factors when assessing suicide risk. Suicide & Life Threatening Behaviour 1991; 21:106-114, Coauthor

  115. Sharma V, O’Reilly RL. Charles Bonnet syndrome [Letter]. Can J Psychiatry, 1991; 36 (4): 311-312, Coauthor

  116. Cooper AJ, O’Reilly RL. An update on the monoamine oxidase inhibitors (MAOIs). Today’s Ther Trends 1991; 9:35-54, Coauthor

  117. O’Reilly RL, Davis B, Durden DA, Thorpe L, Machnee H, Boulton AA. Plasma phenylethylamine in schizophrenic patients. Biol Psychiatry 1991; 30:145-150, Principal Author

  118. O’Reilly RL, Greenwood AM, O’Riordan, WJ. Orthodontic abnormalities in patients with eating disorders. Int Dent J 1991; 41:212-216, Principal Author

  119. Davis BA, Durden DA, O’Reilly RL. The effect of age, sex, weight and height on the plasma concentrations in healthy subjects of the acidic metabolites of some biogenic monoamines involved in psychiatric and neurological disorders. Prog Neuropsychopharmacol Biol Psychiatry 1991; 15:503-512, Collaborator

  120. Davis BA, O’Reilly RL, Placatka C, Paterson A, Yu PH, Durden DA. Effect of dietary phenylalanine on the plasma concentrations of phenylalanine, phenylethylamine and phenylacetic acid in healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry 1991; 15:611-623, Coauthor

  121. O’Reilly RL, Smith D. Benzodiazepines and confusion in medically ill alcoholics. Can Fam Physician 1991; 37:2609-2613, 2644, Principal Author

  122. O’Reilly RL, Rusnak C. The use of sedative hypnotic drugs in a university teaching hospital. Can Med Assoc J 1990; 142:585-589, Principal Author

  123. O’Reilly RL, O’Donovan C, Cernovsky Z. Differences between patients’ relatives’ and physicians’ evaluations of a psychiatric nursing program. J Community Psychol 1990; 18:298-303, Principal Author

  124. O’Reilly RL, Truant G. Psychiatrists’ experience of suicide in their patients. Psychiatr J Univ Ott 1990; 15:173-176, Principal Author

  125. O’Reilly RL, Parker Z. Resolving the conflict of training and therapy in psychiatry. Psychiatr J Univ Ott 1990; 15:28-31, Principal Author

  126. Greenwood AM, O’Reilly RL, O’Riordan WJ, Linden G. The oral and dental manifestations of bulimia nervosa compared with those of anorexia nervosa. J Ir Dent Assoc 1988; 34:26-28, Coauthor

  127. O’Reilly RL, Malhotra L. Capgras syndrome: An unusual case and discussion of psychodynamic factors. Br J Psychiatry 1987; 51:263-265, Principal Author

  128. O’Reilly RL. The Transfer syndrome. Can J Psychiatry, 1987; 32 (8): 674-678, Principal Author